Nonoperative Management for Rectal Cancer.

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• The standard treatment for rectal cancer has historically involved chemoradiotherapy and surgery.
• A shift towards de-escalated treatment strategies is occurring to enhance patient quality of life.
• Organ preservation is a growing consideration in rectal cancer management.

Purpose of the Study:

• To explore the evolving treatment paradigm for rectal cancer, focusing on de-escalated approaches.
• To discuss the role of total neoadjuvant therapy in achieving clinical complete response and enabling organ preservation.
• To highlight the importance of response assessment and surveillance for nonoperative management strategies.

Main Methods:

• Review of current treatment strategies for rectal cancer.
• Analysis of data supporting organ preservation and nonoperative management.
• Discussion of total neoadjuvant therapy (TNT) protocols and their outcomes.

Main Results:

• Total neoadjuvant therapy is associated with the highest rates of clinical complete response in rectal cancer.
• Nonoperative management is emerging as a viable option for select rectal cancer patients.
• Optimal sequencing of radiation and chemotherapy within TNT requires further investigation.

Conclusions:

• De-escalated treatment approaches, including nonoperative management, are becoming standard for rectal cancer.
• Further research is needed on patient selection, monitoring, and patient-reported outcomes for personalized rectal cancer care.
• Optimizing neoadjuvant therapy sequencing is crucial for maximizing treatment efficacy and organ preservation.